Fennec Pharmaceuticals Inc.
|
|||
| Mailing Address: | 68 TW Alexander Drive PO Box 13628 Research Triangle Park, North Carolina 27709 |
Head Office Address: | 68 TW Alexander Drive PO Box 13628 Research Triangle Park, North Carolina 27709 |
| Contact Name: | Robert Andrade | Principal Regulator: | Ontario |
| Business e-mail address: | randrade@fennecpharma.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 919 2465299 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland |
| Fax Number: | Stock Exchange: | TSX, NASDAQ | |
| Date of Formation: | Aug 14 1998 | Stock Symbol: | FRX |
| Jurisdiction Where Formed: | British Columbia | Auditor: | Haskell & White LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 31447P | Transfer Agent: | Computershare Trust Company of Canada |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
